| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Veracyte, Inc. (VCYT) have been net sellers, shedding 32,759 shares worth roughly $1.4M on balance. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
On the other side, 1 insider reduced a position over the period. VCYT sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.1K | $19.39M | - | |
| CFO | 166.0K | $7.26M | - | |
| Other | 135.8K | $5.82M | - | |
| VP | 131.2K | $5.73M | - | |
| Other | 124.3K | $4.97M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Leite John49 | Global Chief Commercial Off | Sell | 13,975 | $50.07 | $699,732.44 | -9.6% | - | - | |
| Jun 4, 2026 | McGuire Annie46 | EVP, General Counsel | Sell | 3,176 | $49.76 | $158,035.98 | -2.3% | - | - | |
| May 22, 2026 | Wygant Jonathan | VP, Chief Accounting Officer | Sale+OE | 24,000 | $45.40 | $1,089,624.00 | -34.6% | - | - | |
| May 20, 2026 | Epstein Robert S | Director | Sell | 10,000 | $44.01 | $440,129.00 | -16.0% | - | - | |
| May 6, 2026 | McGuire Annie46 | SVP, General Counsel | Sell | 10,204 | $39.03 | $398,211.10 | -6.6% | - | - | |
| Mar 4, 2026 | McGuire Annie46 | SVP, General Counsel | Sell | 6,658 | $35.55 | $236,724.83 | -6.6% | - | - | |
| Mar 4, 2026 | Leite John49 | Chief Commercial Officer-clia | Sell | 5,260 | $35.19 | $185,082.57 | -4.7% | - | - | |
| Mar 4, 2026 | Stapley Marc60 | Chief Executive Officer | Sell | 45,523 | $35.97 | $1,637,594.15 | -11.3% | - | - | |
| Mar 4, 2026 | Chambers Rebecca73 | Chief Financial Officer | Sell | 18,341 | $36.14 | $662,869.24 | -12.3% | - | - | |
| Mar 2, 2026 | Febbo Phillip G.63 | Chief Scientific &Med Officer | Sell | 13,425 | $36.16 | $485,429.21 | -10.3% | - | - |